These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 31170413)

  • 21. Interleukin-22 ameliorates liver fibrogenesis by attenuating hepatic stellate cell activation and downregulating the levels of inflammatory cytokines.
    Lu DH; Guo XY; Qin SY; Luo W; Huang XL; Chen M; Wang JX; Ma SJ; Yang XW; Jiang HX
    World J Gastroenterol; 2015 Feb; 21(5):1531-45. PubMed ID: 25663772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flavonoid-rich Scabiosa comosa inflorescence extract attenuates CCl
    Ma Y; Yuan H; Jin R; Bao X; Wang H; Su X; Mu MGSL; Liang J; Zhang J; Wu X
    Biomed Pharmacother; 2018 Oct; 106():426-433. PubMed ID: 29990830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver X receptor signaling is a determinant of stellate cell activation and susceptibility to fibrotic liver disease.
    Beaven SW; Wroblewski K; Wang J; Hong C; Bensinger S; Tsukamoto H; Tontonoz P
    Gastroenterology; 2011 Mar; 140(3):1052-62. PubMed ID: 21134374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway.
    Mu M; Zuo S; Wu RM; Deng KS; Lu S; Zhu JJ; Zou GL; Yang J; Cheng ML; Zhao XK
    Drug Des Devel Ther; 2018; 12():4107-4115. PubMed ID: 30584275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The aryl hydrocarbon receptor ligand ITE inhibits cell proliferation and migration and enhances sensitivity to drug-resistance in hepatocellular carcinoma.
    Zhang X; He B; Chen E; Lu J; Wang J; Cao H; Li L
    J Cell Physiol; 2021 Jan; 236(1):178-192. PubMed ID: 32510618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carvacrol alleviates liver fibrosis by inhibiting TRPM7 and modulating the MAPK signaling pathway.
    Cai S; Wu L; Yuan S; Liu G; Wang Y; Fang L; Xu D
    Eur J Pharmacol; 2021 May; 898():173982. PubMed ID: 33647257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting Src family kinase member Fyn by Saracatinib attenuated liver fibrosis in vitro and in vivo.
    Du G; Wang J; Zhang T; Ding Q; Jia X; Zhao X; Dong J; Yang X; Lu S; Zhang C; Liu Z; Zeng Z; Safadi R; Qi R; Zhao X; Hong Z; Lu Y
    Cell Death Dis; 2020 Feb; 11(2):118. PubMed ID: 32051399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Codonopis bulleynana Forest ex Diels (cbFeD) effectively attenuates hepatic fibrosis in CCl
    Li X; Xing Y; Mao D; Ying L; Luan Y; Xu M; Wang H; Li C; Li Y; Zheng S; Li Z; Hu J; Li Z; Wang H; Luan Y
    Biomed Pharmacother; 2021 Jan; 133():110960. PubMed ID: 33197763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/mTOR/p70S6K and TGFβ/Smad signalling pathways.
    Li J; Li X; Xu W; Wang S; Hu Z; Zhang Q; Deng X; Wang J; Zhang J; Guo C
    Liver Int; 2015 Apr; 35(4):1222-33. PubMed ID: 25040634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The inhibition of Hippo/Yap signaling pathway is required for magnesium isoglycyrrhizinate to ameliorate hepatic stellate cell inflammation and activation.
    Li L; Zhou J; Li Q; Xu J; Qi J; Bian H
    Biomed Pharmacother; 2018 Oct; 106():83-91. PubMed ID: 29957470
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Yan J; Hu B; Shi W; Wang X; Shen J; Chen Y; Huang H; Jin L
    Am J Physiol Gastrointest Liver Physiol; 2021 May; 320(5):G720-G728. PubMed ID: 33728992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of steroid receptor co-activator-3 attenuates carbon tetrachloride-induced murine hepatic injury and fibrosis.
    Ma X; Xu L; Wang S; Chen H; Xu J; Li X; Ning G
    Lab Invest; 2009 Aug; 89(8):903-14. PubMed ID: 19488034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. S-allyl-glutathione improves experimental liver fibrosis by regulating Kupffer cell activation in rats.
    Takemura S; Azuma H; Osada-Oka M; Kubo S; Shibata T; Minamiyama Y
    Am J Physiol Gastrointest Liver Physiol; 2018 Feb; 314(2):G150-G163. PubMed ID: 28971836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cooperation of structurally different aryl hydrocarbon receptor agonists and β-catenin in the regulation of CYP1A expression.
    Vaas S; Kreft L; Schwarz M; Braeuning A
    Toxicology; 2014 Nov; 325():31-41. PubMed ID: 25174530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SOD3 deficiency induces liver fibrosis by promoting hepatic stellate cell activation and epithelial-mesenchymal transition.
    Sun YL; Bai T; Zhou L; Zhu RT; Wang WJ; Liang RP; Li J; Zhang CX; Gou JJ
    J Cell Physiol; 2021 Jun; 236(6):4313-4329. PubMed ID: 33230845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice.
    Meng F; Wang K; Aoyama T; Grivennikov SI; Paik Y; Scholten D; Cong M; Iwaisako K; Liu X; Zhang M; Österreicher CH; Stickel F; Ley K; Brenner DA; Kisseleva T
    Gastroenterology; 2012 Sep; 143(3):765-776.e3. PubMed ID: 22687286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upregulation of matrilin-2 expression in murine hepatic stellate cells during liver injury has no effect on fibrosis formation and resolution.
    Hintermann E; Bayer M; Pfeilschifter JM; Deák F; Kiss I; Paulsson M; Christen U
    Liver Int; 2015 Apr; 35(4):1265-73. PubMed ID: 24905825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of Gab1 adaptor protein in hepatocytes aggravates experimental liver fibrosis in mice.
    Kizu T; Yoshida Y; Furuta K; Ogura S; Egawa M; Chatani N; Hamano M; Takemura T; Ezaki H; Kamada Y; Nishida K; Nakaoka Y; Kiso S; Takehara T
    Am J Physiol Gastrointest Liver Physiol; 2015 Apr; 308(7):G613-24. PubMed ID: 25617348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnesium isoglycyrrhizinate ameliorates liver fibrosis and hepatic stellate cell activation by regulating ferroptosis signaling pathway.
    Sui M; Jiang X; Chen J; Yang H; Zhu Y
    Biomed Pharmacother; 2018 Oct; 106():125-133. PubMed ID: 29957462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis.
    Widjaja AA; Singh BK; Adami E; Viswanathan S; Dong J; D'Agostino GA; Ng B; Lim WW; Tan J; Paleja BS; Tripathi M; Lim SY; Shekeran SG; Chothani SP; Rabes A; Sombetzki M; Bruinstroop E; Min LP; Sinha RA; Albani S; Yen PM; Schafer S; Cook SA
    Gastroenterology; 2019 Sep; 157(3):777-792.e14. PubMed ID: 31078624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.